Press Release – Medicines New Zealand Announcement in the budget today of $200 million over the next four years is simply meeting the Government’s election 2020 promise for funding existing medicines and some new ones. It does nothing to solve the medicines access crisis or medicines …
Announcement in the budget today of $200 million over the next four years is simply meeting the Government’s election 2020 promise for funding existing medicines and some new ones. It does nothing to solve the medicines access crisis or medicines inequity issues for Māori and Pacific peoples, and simply confirms information already leaked to the media earlier this week.
Wednesday 14 April 2021, 12:50 AM
New Zealand takes 2.5 times the OECD average of nine months, to publicly fund modern medicines. Why the delay here? Asks Medicines New Zealand chief Graeme Jarvis
VIEWPOINT
Graeme Jarvis has some questions for the reviewers of funding agency Pharmac to ask as they embark on their work
The Government’s decision to have a review into drug funder Pharmac should be seen both as positive and as good public-sector governance.
This, of
Oops, please login or sign up to read more.LOGINSUBSCRIBE
+Undoctored
Media release from Medicines New Zealand
Tuesday 2 March 2021, 04:18 PM
1 minute to Read
Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of modern medicines and vaccines, is supportive of the proposed review into PHARMAC if it is intended to improve the existing system and enhance modern medicines access for patients and the health system.
“Medicines New Zealand understands any Government’s need to have access to modern medicines in a timely manner, and the current Government has shown it is capable of moving swiftly to fund COVID-19 health measures in as short a timeframe as possible to save the lives of New Zealanders” said Dr Graeme Jarvis, CEO of Medicines New Zealand.
Photo: Andy Dean Photography/ 123rf
Voluntary guidelines have been set out by Medicines New Zealand and the New Zealand Medical Association, asking drug companies to post annual reports on which doctors or health workers received payments and what the payments were for.
Medicines New Zealand chief executive Graeme Jarvis.
Photo: Supplied
Medicines New Zealand chief executive Graeme Jarvis said his organisation was made up of companies researching, making and marketing drugs.
All members, including major drug manufacturers Pfizer and GSK, had agreed to disclose payments to health workers, he said.
Jarvis hoped the guidelines would increase public trust in the payments, which some researchers have said influence how doctors prescribe drugs for patients.
Drug companies will reveal when they pay doctors to attend events msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.